title: Linear immunoglobulin A bullous dermatosis associated with herpes simplex virus infection and Kawasaki disease.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hayashi
authors.forename: Fumiko
authors.initials: F
authors.lastname: Monma
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Katagiri
authors.forename: Masakazu
authors.initials: M
authors.lastname: Kawaguchi
authors.forename: Tamio
authors.initials: T
authors.lastname: Suzuki
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001485:Basement Membrane / Q000276:immunology / Q000473:pathology; D003622:Dapsone / Q000627:therapeutic use; D006023:Glycoproteins / Q000627:therapeutic use; D006561:Herpes Simplex / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007070:Immunoglobulin A / Q000276:immunology*; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000821:virology
chemical_list: D006023:Glycoproteins; D007070:Immunoglobulin A; D003622:Dapsone; D011239:Prednisolone; C028665:urinastatin; D001241:Aspirin; D000212:Acyclovir